NYSE: UNH · Health Care · Health insurers · Insurance

UnitedHealth Group Incorporated

UnitedHealth Group runs UnitedHealthcare, the largest US health insurer, and Optum’s clinics, health IT and Optum Rx pharmacy benefit manager.

Our rating
Sell
12-month target
$297.81
Price, Nov 18, 2026
$349.91
Expected return, with dividend
−12%

Latest research: initiation, Nov 20, 2026Market value $315,600m

UNHSellTarget $297.81−12% expected
Our UNH model 15 sheets: Summary, Thesis, Market Check, Assumptions, … · Updated Nov 20, 2026 Free to view Open the model
$349.91Price $297.8112-month target
Implied return -15% to our target. Bear to bull $168.75 to $428.07, from our initiation of Nov 20, 2026. We expect a total return worse than −10% over the next 12 months: a fall of more than 10%, after dividends.

Primary P/E: 11.5x (restated peer median) on FY27E adjusted EPS of $23.52, less $4.08 of expected RADV cost, gives a $266.36 base value. Bear, base and bull values of $168.75, $266.36 and $428.07 are weighted 25/50/25% to $282.39 and rolled forward 12 months at 5.46% (8.18% cost of equity less the 2.72% dividend yield) to the $297.81 target. A 10-year FCFE DCF cross-check gives $537.

Bear case
$168.75
-52% from $349.91
  • FY27E adjusted EPS $17.18 at 10.5x lowest-peer P/E
  • $11.66 full RADV (100% upheld)
  • UHC margin 3.0%
  • Optum Health margin 2.0%
Base case
$266.36
-24% from $349.91
  • FY27E adjusted EPS $23.52 at 11.5x peer-median P/E
  • $4.08 RADV deduction (35% upheld)
  • UHC margin 4.1%
  • Optum Health margin 4.0%
Bull case
$428.07
+22% from $349.91
  • FY27E adjusted EPS $26.75 at 16.0x best-peer P/E
  • UHC margin 4.6%, Optum Health 5.0%
  • Medicare & Retirement +7.0%
  • RADV vacated ($0)
Base value
$266.36
Target P/E (FY27E)
11.5x
P/E at current price (FY27E)
14.9x
Expected RADV cost
$4.08/sh
Cost of equity
8.18%
FCFE DCF value
$537
Price-implied UHC margin FY27E
6.39%

Our estimates

LineFY26EFY27EFY28E
Revenue$449.8bn$464.8bn$487.2bn
Consensus$446.9bn——
Ours vs consensus+0.7%——
EPS$20.73$23.52$27.35
Consensus$20.59$23.29—
Ours vs consensus+0.7%+1.0%—

Sign in to Penmark